Dr Hannah Chan
Hannah Chan has worked in the Meningococcal Vaccines group at NIBSC since 2002. Her main research interests lie in the development and pre-clinical testing of novel vaccines and adjuvants, particularly those based on the meningococcal antigens PorA, FetA and other outer membrane proteins. She has worked on the development of a multiplex assay to measure serological responses to different antigenic variants for PorA and FetA.
Hannah works alongside Caroline Vipond and Rory Care, managing the Meningococcal / Pneumococcal Vaccines group and oversees the majority of the batch release of meningococcal conjugate vaccines.
In addition, Hannah leads projects for the development and maintenance of meningococcal reference materials.
Hannah obtained her PhD from the University of Birmingham in 2002 and a degree in Applied Biology from Imperial College in 1998.